Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- France
- Sweden
- Spain
- Netherlands
- Poland
- Portugal
- Finland
- Belgium
- Switzerland
- Canada
- Italy
- Austria
- Norway
- Denmark
- Morocco
- Singapore
- Czech
- United Arab Emirates
- Australia
- Brazil
- Japan
- Ireland
- Hong Kong
- India
- Luxembourg
- South Africa
- China
- Hungary
- Latvia
- Croatia
- Greece
- Malta
- Mexico
- New Zealand
- Romania
- Slovenia
- South Korea
- Taiwan
- 31 more »
- « less
-
Program
-
Field
-
of experimental data generated through immunocytochemistry, molecular biology, and imaging techniques. Where to apply Website https://pica.cineca.it/ Requirements Additional Information Eligibility criteria
-
interpretable models of molecular disease mechanisms, with a focus on identifying proteins and pathways involved in cardiovascular disease. PhD project: Causal multi-omics modeling of disease biology We
-
Biomedical and Translational Sciences/Weill Institute for Cell and Molecular Biology - Assistant Professor Molecular Therapeutics Biomedical and Translational Sciences/Weill Institute for Cell and
-
infection and inflammation. The successful candidate will lead and contribute to research projects using molecular and cell biology, biochemistry, cell culture, viral infection models, and mouse models
-
,Department of Molecular Biology. For questions contact Yuri Schwartz, [email protected] We look forward to receiving your application! Where to apply Website https://umustipendie.varbi.com/en/what:job/jobID
-
Posting Details Posting Details Job Title Scientist I Requisition Number RE55801 Working Title Scientist I Department Name 7H180:Molecular and Cellular Biochemistry Work Location Lexington, KY Grade
-
with LP2M teams (immunology, iPSC models) as well as from the project's international clinical and scientific network (Prof. Claus Peter Schmitt, Heidelberg; UCA GenomiX and MICA platforms, Nice
-
Position Description The Weill Institute for Cell and Molecular Biology (WICMB) and the Department of Biomedical and Translational Sciences (BTS) at Cornell University in Ithaca, NY invite
-
, rational drug design, and molecular modeling to improve potency, isoform selectivity, and drug-like properties. The project also involves the multistep synthesis, purification, and structural
-
at https://biffilab.wordpress.com Pancreatic ductal adenocarcinoma (PDAC) remains a formidable clinical challenge. A major recent advance has been the development of KRAS inhibitors, which have shown